Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Merck Throws a Wrench in Drug Pricing

Volume may help Merck make up what it loses on price. AbbVie and Gilead's drugs are priced so high that many governments and insurers will only pay for them for patients that have severe liver scarring, given HCV's slow progression. Zepatier is priced at a point that could make it affordable to treat a much larger population at earlier stages of the disease.

Published
01 February 2016
From
Bloomberg
New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

Merck has received a US license for its direct-acting antiviral combination of grazoprevir and elbasvir, to be marketed as Zepatier. The combination of grazoprevir (an HCV protease inhibitor)

Published
01 February 2016
By
Keith Alcorn
Only 3 Presidential Candidates Share How They Will Address HIV

Only 3 out of the 16 candidates running for president answered GMHC's survey on how they plan to govern on issues concerning HIV.

Published
01 February 2016
From
HIVPlus
HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later

In summary, in the past eight years one randomised and two on-going observational trials continue to support the “no-risk” hypothesis of the Swiss statement, while the basis for the statement – the absence of observed cases – has further increased over time. Perhaps the most important legacy of the Swiss statement has been the empowerment of people living with HIV.

Published
30 January 2016
From
Swiss Medical Weekly
California Doles Out Millions to Insurers for Hepatitis C Drugs

In an unusual funding arrangement, California is paying private health plans hundreds of millions of dollars in supplemental payments to cover the high price of hepatitis C drugs for patients in Medi-Cal managed care plans.

Published
29 January 2016
From
KQED News
London sexual health clinics step up their support for people buying PrEP online

Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring

Published
29 January 2016
By
Roger Pebody
Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

The attorney general of Massachusetts said on Wednesday that she had opened an inquiry into whether Gilead Sciences had violated state consumer protection laws by charging too much for its hepatitis C drugs.

Published
28 January 2016
From
New York Times
Massachusetts official challenges Gilead's hepatitis C drug prices

Massachusetts' attorney general is studying whether prices of Gilead Sciences' blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California-based drugmaker.

Published
28 January 2016
From
Reuters
About that latest big Gates Foundation bet for HIV prevention

It isn’t too out of the ordinary for Gates Foundation grant awards to soar into the eight- and even nine-figure range. So, its $20 million grant to Moderna Therapeutics to support its continuing development of a novel but promising HIV prevention therapy isn’t particularly extraordinary. But what is unusual...is that the total potential commitment from the foundation could reach upwards of $100 million—around 70 percent of the Gates Foundation’s HIV/AIDS grants for all of last year.

Published
27 January 2016
From
Inside Philanthropy
PEPFAR's Dr Deborah Birx urges sharper focus to halt HIV globally

To protect and extend the significant progress made against the HIV/AIDS epidemic globally, policymakers and funders must target specific high-risk populations, especially young women in sub-Saharan Africa, according to U.S. Global AIDS Coordinator, Dr. Deborah Birx, who oversees the President's Emergency Plan for AIDS Relief (PEPFAR).

Published
27 January 2016
From
Fogarty International Center

Filter by country